ACCOUNTS - Final Accounts preparation


Caseware UK (AP4) 2021.0.152 2021.0.152 2022-08-312022-08-31trueNo description of principal activitytrue12021-09-01true1 01128997 2021-09-01 2022-08-31 01128997 2020-09-01 2021-08-31 01128997 2022-08-31 01128997 2021-08-31 01128997 c:Director1 2021-09-01 2022-08-31 01128997 d:PatentsTrademarksLicencesConcessionsSimilar 2022-08-31 01128997 d:PatentsTrademarksLicencesConcessionsSimilar 2021-08-31 01128997 d:CurrentFinancialInstruments 2022-08-31 01128997 d:CurrentFinancialInstruments 2021-08-31 01128997 d:CurrentFinancialInstruments d:WithinOneYear 2022-08-31 01128997 d:CurrentFinancialInstruments d:WithinOneYear 2021-08-31 01128997 d:ShareCapital 2022-08-31 01128997 d:ShareCapital 2021-08-31 01128997 d:RetainedEarningsAccumulatedLosses 2022-08-31 01128997 d:RetainedEarningsAccumulatedLosses 2021-08-31 01128997 c:OrdinaryShareClass1 2021-09-01 2022-08-31 01128997 c:OrdinaryShareClass1 2022-08-31 01128997 c:OrdinaryShareClass1 2021-08-31 01128997 c:EntityNoLongerTradingButTradedInPast 2021-09-01 2022-08-31 01128997 c:FRS102 2021-09-01 2022-08-31 01128997 c:AuditExempt-NoAccountantsReport 2021-09-01 2022-08-31 01128997 c:FullAccounts 2021-09-01 2022-08-31 01128997 c:PrivateLimitedCompanyLtd 2021-09-01 2022-08-31 01128997 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2021-09-01 2022-08-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 01128997









CYBERMED (U.K.) LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 AUGUST 2022

 
CYBERMED (U.K.) LIMITED
REGISTERED NUMBER: 01128997

BALANCE SHEET
AS AT 31 AUGUST 2022

2022
2021
Note
£
£

Fixed assets
  

Intangible assets
 5 
28,346
39,671

  
28,346
39,671

  

Creditors: amounts falling due within one year
 6 
(143,366)
(128,633)

Net current liabilities
  
 
 
(143,366)
 
 
(128,633)

Total assets less current liabilities
  
(115,020)
(88,962)

  

Net liabilities
  
(115,020)
(88,962)


Capital and reserves
  

Called up share capital 
 7 
100
100

Profit and loss account
  
(115,120)
(89,062)

  
(115,020)
(88,962)

Page 1

 
CYBERMED (U.K.) LIMITED
REGISTERED NUMBER: 01128997
    
BALANCE SHEET (CONTINUED)
AS AT 31 AUGUST 2022

For the year ended 31 August 2022 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 7 February 2023.




M B Hughes
Director

The notes on pages 3 to 5 form part of these financial statements.
Page 2

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2022

1.


General information

The Company is a private company, limited by shares, incorporated and domiciled in England within the United Kingdom, registration number 01128997. The Company's registered office is 18 Hartford Close, Harborne, Birmingham, B17 8AU.
The financial statements are presented in sterling which is the functional currency of the company and the financial statements are rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

Cash flow
Under Financial Reporting Standard 102, the company is exempt from the requirement to prepare a cash flow statement on the grounds that it qualifies as a small company.

 
2.2

Going concern

The company has made losses and as such has net liabilities at the balance sheet date.  The main creditors of the company are the director and shareholders who intend to continue to support the company for the foreseeable future and the director therefore considers it appropriate to prepare the accounts on a going concern basis.

 
2.3

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.4

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.5

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid
Page 3

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2022

2.Accounting policies (continued)


2.5
Financial instruments (continued)

or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2021 - 1).


4.


Taxation

The company has trading tax losses of £110,256 (2021 - £84,207) available to offset against future trading profits.


5.


Intangible assets




Patents

£



Cost


At 1 September 2021
50,996



At 31 August 2022

50,996



Amortisation


At 1 September 2021
11,325


Charge for the year on owned assets
11,325



At 31 August 2022

22,650



Net book value



At 31 August 2022
28,346



At 31 August 2021
39,671



Page 4

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2022

6.


Creditors: Amounts falling due within one year

2022
2021
£
£

Other creditors
142,646
127,913

Accruals and deferred income
720
720

143,366
128,633



7.


Share capital

2022
2021
£
£
Allotted, called up and fully paid



100 (2021 - 100) Ordinary shares of £1.00 each
100
100



8.


Related party transactions

As at 31 August 2021 amounts due to the director was £82,374 (2021 - £67,641) and amounts due to shareholders were £60,272 (2021 - £60,272).
All loans are interest free and repayable on demand.

 
Page 5